Not for release, publication, or distribution, in whole or in part directly or
indirectly, in Australia, Canada, the Hong Kong Special Administrative Region of
the People's Republic of China, Japan, or the United States (or any other
jurisdiction in which the release, publication or distribution would be
unlawful). This announcement does not constitute an offer of any of the
securities described herein.

Reference is made to the stock exchange notice from SoftOx Solutions AS (the
"Company") regarding the Rights Issue of up to 1,237,508,259 new shares in the
Company.

The period for trading in subscription rights for the Rights Issue will expire
today, Monday 19 August at 16:30 (CEST). Subscription rights for participation
in the Rights Issue can be exercised during the ongoing subscription period,
which will expire on Friday 23 August at 16:30 (CEST).

Subscription rights that are not used to subscribe for new shares before the
expiry of the subscription period on Friday 23 August at 16:30 (CEST), or not
sold before Monday 19 August at 16:30 (CEST), will have no value and will lapse
without compensation to the holder.

For more information, please refer to the Prospectus for the Rights Issue dated
5 August 2024.

For any questions please contact: 
Geir Almås, Chair of SoftOx Solutions AS 
Mail: ir@soft-ox.com 
Phone: Geir Almås: (+47) 977 59 071 
About SoftOx Solutions AS 

SoftOx Solutions AS (SoftOx) is a Medtech and pharmaceutical company listed on
Euronext Growth Oslo under 'SOFTX'. SoftOx Solutions AS was founded in 2012 and
is headquartered in Oslo. The SoftOx Solutions Group includes the holding
company SoftOx Solutions AS, the Malmö subsidiary Water Innovation AB, and
subsidiaries SoftOx Defense Solutions AS and SoftOx Disinfection AS. SoftOx is
developing a highly effective antimicrobial solution for biofilm, viral, and
antimicrobial-resistant infections. The patent-protected technology is based on
extensive research and development in partnership with leading Nordic research
institutes.

For more information on SoftOx, visit www.soft-ox.com

IMPORTANT NOTICES 
This announcement is not and does not form a part of any offer to sell, or a
solicitation of an offer to purchase, any securities of the Company. The
distribution of this announcement and other information may be restricted by law
in certain jurisdictions. Copies of this announcement are not being made and may
not be distributed or sent into any jurisdiction in which such distribution
would be unlawful or would require registration or other measures. Persons into
whose possession this announcement or such other information should come are
required to inform themselves about and to observe any such restrictions. The
securities referred to in this announcement have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the "Securities
Act"), and accordingly may not be offered or sold in the United States absent
registration or an applicable exemption from the registration requirements of
the Securities Act and in accordance with applicable U.S. state securities laws.
The Company does.